目的 制备黏膜免疫佐剂Chi-CpG NP,探究其对结核分枝杆菌ESAT-6疫苗免疫保护效应的增强作用。方法 采用离子交联法制备Chi-CpG NP并检测其理化性质;将雌性BALB/c小鼠随机分为PBS对照组、ESAT-6组、ESAT-6+CpG组、ESAT-6+Chi NP组、ESAT-6+Chi-CpG NP组,经鼻腔黏膜免疫后,于第42天检测小鼠体液免疫(IgG、IgG1、gG2a、sIgA)和细胞免疫水平[γ干扰素(IFN-γ)、白细胞介素(IL)-4、IL-17A];经腹腔注射结核分枝杆菌H37Rv进行攻毒实验,感染后4周观察肺组织病理损伤程度。结果 成功制备的Chi-CpG NP呈规则球形,有较好的蛋白吸附功能。免疫后42d,ESAT-6+Chi-CpG NP组小鼠血清IgG、IgG1、IgG2a及鼻、阴道黏膜sIgA水平均显著高于其它实验组(P<0.05),脾细胞上清中IFN-γ、IL-2、IL-17A分泌水平均为各组最高(P<0.05);此外,ESAT-6+Chi-CpG NP组肺组织炎性浸润程度最轻。结论 Chi-CpG NP可有效增强ESAT-6疫苗诱导的体液免疫、黏膜免疫及细胞免疫应答,显著提升小鼠对结核分枝杆菌感染的抵抗能力。
结核分枝杆菌;ESAT-6抗原;黏膜免疫佐剂;Chi-CpG NP
[1]Kisimba K,Kasumbwe K,Odun-Ayo F,et al.Flavonoids:Potential Novel Inhibitors of Mycobacterium tuberculosis[J].Infect Disord Drug Targets,2025,25(8):e18715265361578.
[2]Ferluga J,Yasmin H,Bhakta S,et al.Vaccination Strategies Against Mycobacterium tuberculosis:BCG and Beyond[J].Adv Exp Med Biol,2021,1313:217-240.
[3]Bouzeyen R,Javid B.Therapeutic Vaccines for Tuberculosis:An Overview[J].Front Immunol,2022,13:878471.
[4]Singh DK,Ahmed M,Akter S,et al.Prevention of tuberculosis in cynomolgus macaques by an attenuated Mycobacterium tuberculosis vaccine candidate[J].Nat Commun,2025,16(1):1957.
[5]李玉洁,余海燕,杨雨婷,等.结核分枝杆菌分泌蛋白早期分泌性抗原6(ESAT-6)的免疫学性质及其在新型疫苗中作用的研究进展[J].细胞与分子免疫学杂志,2024,40(01):89-94.
[6]Blanco FC,Vázquez CL,García EA,et al.Mycobacterium bovis mutant in the virulence factors PhoP,ESAT-6 and CFP-10 persisted in mouse organs after a year post-vaccination[J].Tuberculosis(Edinb),2024,149:102574.
[7]Wang Y,Liu S,Li B,et al.A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus[J].Front Immunol,2024,15:1336239.
[8]Li Z,Li Y,Wang Y,et al.Intranasal immunization with a rNMB0315 and combination adjuvants induces protective immunity against Neisseria meningitidis serogroup B in mice[J].Int Immunopharmacol,2021,93:107411.
[9]王丽梅.结核病黏膜疫苗的研究进展[J].中国人兽共患病学报,2022,38(02):170-174,181.
[10]李文桂,陈雅棠.载体介导的结核分枝杆菌ESAT-6疫苗的研制现状[J].热带医学杂志,2024,24(02):299-304.
[11]Jiang T,Ji H,Zhang L,et al.Chitosan Oligosaccharide Exerts Anti-Allergic Effect against Shrimp Tropomyosin-Induced Food Allergy by Affecting Th1 and Th2 Cytokines[J].Int Arch Allergy Immunol,2019,180(01):10-16.
[12]White AD,Tran AC,Sibley L,et al.Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates[J].Front Immunol,2023,14:1246826.
[13]Slovakova M,Janovska S,Sleha R,et al.Nasal Immunization Using Chitosan Nanoparticles with Glycoprotein B of Murine Cytomegalovirus[J].J Microbiol Biotechnol,2024,34(3):663-672.
[14]Chuang CC,Tsai MH,Yen HJ,et al.A fucoidan-quaternary chitosan nanoparticle adjuvant for anthrax vaccine as an alternative to CpG oligodeoxynucleotides[J].Carbohydr Polym,2020,229:115403.
[15]Li Z,He Y,Deng L,et al.A fast-dissolving microneedle array loaded with chitosan nanoparticles to evoke systemic immune responses in mice[J].J Mater Chem B,2020,8(2):216-225.
[16]邢佳音,赵祥祥,孙铭瑞,等.疫苗佐剂研究进展[J].中国生物工程杂志,2025,45(10):64-76.